Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports 5 National Symposium and 1 open acess articles is presently dedicated exclusively to Diabetes medications.
Diabetes medicines help keep your blood glucose in your target range. The target range is suggested by diabetes experts and your doctor or diabetes educator. Drugs used in diabetes treat diabetes mellitus by lowering glucose levels in the blood.The main aim of diabetes medication is that we can restore and maintain the normal pancreas function. The B-cell regeneration, insulin biomarker and cell therapy plays a major role in mainting the diabetes or blood glucose at normal level. Several non-invasive approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections in order to improve patient compliance.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors. Several groups of drugs, mostly given by mouth, are effective in Type II, often in combination. The therapeutic combination in Type II may include insulin, not necessarily because oral agents have failed completely, but in search of a desired combination of effects. The great advantage of injected insulin in Type II is that a well-educated patient can adjust the dose, or even take additional doses, when blood glucose levels measured by the patient, usually with a simple meter, as needed by the measured amount of sugar in the blood. Over time, high levels of blood glucose, also called blood sugar, can cause health problems. These problems include heart disease, heart attacks, strokes, kidney disease, nerve damage, digestive problems, eye disease, and tooth and gum problems. Everyone with diabetes needs to choose foods wisely and be physically active. If you can't reach your target blood glucose levels with wise food choices and physical activity, you may need diabetes medicines. The kind of medicine you take depends on your type of diabetes, your schedule, and your other health conditions.
Market Analysis:
The analysis shows human insulins and analogues dominated the antidiabetics market in 2012. Furthermore, that submarket will maintain dominance in the overall diabetes treatments market to 2023. Also, rapid uptake of dipeptidyl peptidase (DPP)-4 inhibitors will stimulate overall revenue growth, owing to their safety profiles and once-daily dosage regimens. The overall diabetes drugs market will thus achieve strong growth to 2013, especially from 2013 to 2017. Its future is promising, based on existing drugs and agents under development. It has strong, broad-ranging R&D.
International symposium and workshops
List of Best International Conferences:
Aug 22-24, 2016, Sao Paulo, Brazil
November 02-04, 2015 Atlanta, Georgia, USA
February 29-March 02, 2016 Philadelphia, USA
June 06-08, 2016 Dallas, USA
Dec 5-7, 2016, Baltimore, USA
Nov 14-16, 2016, Dubai, UAE
Oct 20-22, 2016, Dubai, UAE
September 29-October 1, 2016, Toronto, Canada
Oct 17-19, 2016, Kuala Lumpur, Malaysia
Aug 22-24, 2016, Kuala Lumpur, Malaysia
Aug 8-10, 2016, Birmingham, UK
July 14-16, 2016, Cologne, Germany
July 11-13, 2016, Brisbane, Australia
Feb 29-Mar 2, 2016, Philadelphia, USA
Relevant Society and Associations
Companies
This page will be updated regularly.
This page was last updated on November 22, 2024
